Corimmun
Martinsried
About Corimmun
Corimmun is a clinical drug developing company located in Martinsried near Munich, Germany, and is focused on novel therapeutics and diagnostics for heart and vascular diseases. Corimmun's activities and experiences comprise all steps from research to drug development and commercialization.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $18.4M
- Funding stage: M&A
- Last round: Series B (Oct 2010)
- Website: corimmun.com
- Phone: +49 89 8565 2010
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Canonical: https://fsome.com/organization/corimmun-2122994 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.